GTC
ALPN

Ghost Tree Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Ghost Tree Capital’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-664,132
Closed -$7.6M – 82
2023
Q3 		$7.6M Buy
664,132
+316,700
+91% +$3.9M 2.5% 11
2023
Q2 		$3.57M Buy
347,432
+147,432
+74% +$1.33M 1.18% 26
2023
Q1 		$1.54M Buy
+200,000
New +$1.59M 0.46% 45
2015
Q3 		– Sell
-12,500
Closed -$758K – 97
2015
Q2 		$758K Buy
+12,500
New +$745K 0.25% 60

Other funds holding ALPN

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ghost Tree Capital's ALPN Position: Q4 2023 in Review

Ghost Tree Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q4 2023, closing a stake of 664,132 shares — an estimated $7.6M sold.

Ghost Tree Capital first reported a position in ALPN in Q2 2015 and held it in 4 quarters. The position peaked at $7.6M in Q3 2023. 133 funds tracked by Wall St. Rank hold ALPN as of Q4 2023.

  • Ghost Tree Capital reported no remaining Alpine Immune Sciences Inc position as of Q4 2023 after selling out during the quarter.
  • Ghost Tree Capital sold 664,132 Alpine Immune Sciences Inc shares in Q4 2023, an estimated $7.6M.
  • Ghost Tree Capital first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 4 quarters.
  • Ghost Tree Capital's Alpine Immune Sciences Inc position peaked at $7.6M in Q3 2023.
  • 133 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2023.

Based on Ghost Tree Capital's 13F filing for Q4 2023, filed 14 Feb 2024.